Weiss Multi-Strategy Advisers’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio KBIO Stock Details KBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-25,000	Closed	-$346K	–	593
2014 Q4	$346K	Hold	25,000	–	–	0.01%	358
2014 Q3	$310K	Hold	25,000	–	–	0.01%	473
2014 Q2	$456K	Hold	25,000	–	–	0.01%	534
2014 Q1	$542K	Sell	25,000 -4,375	-15%	-$127K	0.01%	625
2013 Q4	$1.04M	Hold	29,375	–	–	0.02%	428
2013 Q3	$1.06M	Buy	+29,375	New	+$1.34M	0.02%	404

Other funds holding KBIO

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

OPPM

Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

OWIM

Old West Investment Management Los Angeles, California $923M AUM 112.31% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Weiss Multi-Strategy Advisers's KBIO Position: Q1 2015 in Review

Weiss Multi-Strategy Advisers sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q1 2015, closing a stake of 25,000 shares — an estimated $346K sold.

Weiss Multi-Strategy Advisers first reported a position in KBIO in Q3 2013 and held it in 6 quarters. The position peaked at $1.06M in Q3 2013. 24 funds tracked by Wall St. Rank hold KBIO as of Q1 2015.

Weiss Multi-Strategy Advisers reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q1 2015 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 25,000 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q1 2015, an estimated $346K.
Weiss Multi-Strategy Advisers first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q3 2013 and held it in 6 quarters.
Weiss Multi-Strategy Advisers's KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $1.06M in Q3 2013.
24 funds tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q1 2015.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2015, filed 15 May 2015.